CLINICAL_TRIALS
trial_result
· 2017-06-20
Clinical Trial Update: Dasatinib in Polycythemia Vera [Phase 2]
Summary
A Phase 2 trial of dasatinib in polycythemia vera was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Polycythemia Vera | Phase 2 | Status: TERMINATED | Results posted: 2017-06-20